Cargando…

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study

BACKGROUND: Mid-regional pro-adrenomedullin (MR-proADM), an endothelium-related peptide, is a predictor of death and multi-organ failure in respiratory infections and sepsis and seems to be effective in identifying COVID-19 severe forms. The study aims to evaluate the effectiveness of MR-proADM in c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montrucchio, Giorgia, Sales, Gabriele, Balzani, Eleonora, Lombardo, Davide, Giaccone, Alice, Cantù, Giulia, D'Antonio, Giulia, Rumbolo, Francesca, Corcione, Silvia, Simonetti, Umberto, Bonetto, Chiara, Zanierato, Marinella, Fanelli, Vito, Filippini, Claudia, Mengozzi, Giulio, Brazzi, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080079/ https://www.ncbi.nlm.nih.gov/pubmed/37035317 http://dx.doi.org/10.3389/fmed.2023.1122367

Ejemplares similares

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Effects of Steroids and Tocilizumab on the Immune Response Profile of Patients with COVID-19-Associated ARDS Requiring or Not Veno-Venous Extracorporeal Membrane Oxygenation
por: Fanelli, Vito, et al.
Publicado: (2021)

Trichoderma spp.-Related Pneumonia: A Case Report in Heart–Lung Transplantation Recipient and a Systematic Literature Review
por: Burzio, Carlo, et al.
Publicado: (2023)

Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature
por: Burzio, Carlo, et al.
Publicado: (2023)

ECMO Support and Operator Safety in the Context of COVID-19 Outbreak: A Regional Center Experience
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Prognostic Value of Mid-Regional Proadrenomedullin Sampled at Presentation and after 72 Hours in Septic Patients Presenting to the Emergency Department: An Observational Two-Center Study
por: Bima, Paolo, et al.
Publicado: (2022)

Effectiveness of an Active and Continuous Surveillance Program for Intensive Care Units Infections Based on the EPIC III (Extended Prevalence of Infection in Intensive Care) Approach
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball
por: Montrucchio, G., et al.
Publicado: (2020)

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements
por: Montrucchio, G., et al.
Publicado: (2021)

Pro-adrenomedullin as prognostic biomarker in the sepsis
por: De La Torre-Prados, M, et al.
Publicado: (2013)

Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke
por: Ishiyama, Hiroyuki, et al.
Publicado: (2022)

Adrenomedullin Is a Diagnostic and Prognostic Biomarker for Acute Intracerebral Hemorrhage
por: Julián-Villaverde, Francisco J., et al.
Publicado: (2021)

A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker
por: Solé-Ribalta, Anna, et al.
Publicado: (2022)

Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin
por: Sozio, Emanuela, et al.
Publicado: (2022)

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
por: Önal, Uğur, et al.
Publicado: (2018)

Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with?
por: Corcione, Silvia, et al.
Publicado: (2023)

A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold
por: Lupia, Tommaso, et al.
Publicado: (2022)

Diagnostic value of mid-regional pro-Adrenomedullin as a biomarker of invasive bacterial infection in children: a systematic review
por: Corr, Michael Paul, et al.
Publicado: (2022)

Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study
por: Koyama, Teruhide, et al.
Publicado: (2021)

Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study
por: Oblitas, Crhistian-Mario, et al.
Publicado: (2021)

Bloodstream Infections Caused by Carbapenem-Resistant Pathogens in Intensive Care Units: Risk Factors Analysis and Proposal of a Prognostic Score
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Antimicrobial Prophylaxis in Extracorporeal Membrane Oxygenation: Is the Debate Still Open?
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo?
por: Baranello, Cinzia, et al.
Publicado: (2012)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

Author Correction: Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study
por: Koyama, Teruhide, et al.
Publicado: (2021)

Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
por: Casadei, Giulia, et al.
Publicado: (2021)

Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study
por: Bronton, Kevin, et al.
Publicado: (2021)

Adrenomedullin and tumour angiogenesis
por: Nikitenko, L L, et al.
Publicado: (2006)

Adrenomedullin and tumour microenvironment
por: Larráyoz, Ignacio M, et al.
Publicado: (2014)

Adrenomedullin and cardiovascular diseases
por: Wong, Hoi Kin, et al.
Publicado: (2012)

Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: An Italian cohort study
por: Sacerdote, Carlotta, et al.
Publicado: (2022)

Oligopeptides as Biomarkers of Cyanobacterial Subpopulations. Toward an Understanding of Their Biological Role
por: Agha, Ramsy, et al.
Publicado: (2014)

First Cases of Candida auris in a Referral Intensive Care Unit in Piedmont Region, Italy
por: Corcione, Silvia, et al.
Publicado: (2022)

Thrombopoietin as Biomarker and Mediator of Cardiovascular Damage in Critical Diseases
por: Lupia, Enrico, et al.
Publicado: (2012)

SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study
por: Christ-Crain, Mirjam, et al.
Publicado: (2005)

Dual Role of Extracellular Vesicles in Sepsis-Associated Kidney and Lung Injury
por: Quaglia, Marco, et al.
Publicado: (2022)

Diagnostic and prognostic usefulness of mid-regional pro-adrenomedullin levels in patients with severe sepsis
por: Valenzuela Sanchez, F, et al.
Publicado: (2015)

Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS
por: de Montmollin, Etienne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_luhhm533tr6lljndmn8jghuarf